Brege Laura bought ACAD
May 29, 2026 · Form 4 insider transaction
Brege Laura bought 8,107 shares of ACADIA Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,107
Price
N/A
Total value
N/A
InsiderBrege Laura
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 29, 2026
Filing dateJune 1, 2026
Shares owned after23,202
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.